Kirsten Lawson summarises the ECoWeB PROMOTE and PREVENT trials in relation to self-helps apps for promoting wellbeing and preventing mental ill health among young adults.
[read the full story...]
In their debut blog, Lee Valentine summarises a large-scale updated meta-analysis investigating the effectiveness of mental health apps for depression and anxiety.
[read the full story...]
Giulia Piazza and Jonathan Roiser explore a recent network analysis and ecological momentary assessment study, which provides clear evidence that the relationships between depressive symptoms vary between individuals with depression who are matched on overall depression severity.
[read the full story...]
Holly Fraser discusses new findings on whether and how we can predict antidepressant response using artificial intelligence.
[read the full story...]
Katie Marwick on a new UK Biobank study which suggests that the two years either side of the final menstrual period represent a time of small increased risk for new onset bipolar and major depressive disorder.
[read the full story...]
Lottie Shipp appraises a qualitative study that explored young people’s experiences of their sibling being admitted to a mental health inpatient unit.
[read the full story...]
Ellie Davis highlights a retrospective cohort study that explored eating disorder treatment outcomes between transgender, gender diverse and cisgender adolescents.
[read the full story...]
Georgie Parker summarises a prospective 2-year longitudinal cohort study investigating the course and predictors of outcome in avoidant/restrictive food intake disorder (ARFID) in young people.
[read the full story...]
In her debut blog, Ana Julia Ferreira summarises a randomised controlled trial investigating the effectiveness of a digital self-help intervention for improving bulimic-spectrum disorder symptomatology while on a treatment waiting list.
[read the full story...]
Kirsten Lawson summarises a new ‘state of the art review’ in the BMJ which focuses on novel and emerging pharmacotherapy and neuromodulation for people with ‘treatment resistant depression’.
[read the full story...]
